![]() |
|
|
Vol. 28, Issue 10, 1202-1209, October 2000
TNO BIBRA International Ltd., Surrey, United Kingdom (A.B.R., P.T.B., R.J.P., B.G.L.); Section on Clinical Pharmacology, Division of Medicine, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom (P.S.W., R.J.E., A.R.B.); ENS BANA, Université de Bourgogne, Dijon, France (I.G.); Institute of Liver Studies, Guy's, King's and St. Thomas' School of Medicine, London, United Kingdom (J.M.T.); and Department of Pharmacology and Toxicology, University of Oulu, Oulu, Finland (O.P.)
| |
Abstract |
|---|
|
|
|---|
The maintenance of the major hepatic cytochrome P450 (CYP) enzymes
has been studied in precision-cut human liver slices cultured for up to
72 h in supplemented RPMI 1640 medium. The relative apoprotein
levels of 11 CYP enzymes were determined using a panel of antipeptide
antibodies. In addition, 7-ethoxyresorufin O-deethylase, tolbutamide methylhydroxylase, debrisoquine 4-hydroxylase, and testosterone 6
-hydroxylase activities were determined as enzymatic markers for CYP1A2, CYP2C9, CYP2D6, and CYP3A4, respectively. There was
a large variation in the rate of decline of different CYP levels with
time in culture. Based on the rate of decrease, CYP enzymes could be
separated into two groups, with CYP2C9, CYP2D6, CYP3A4, and CYP4A11
being relatively stable (half-lives between 70 and 104 h),
compared with CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, and
CYP3A5, which were relatively unstable (half-lives between 23 and
36 h). Enzyme activities decreased at rates similar to those of
their corresponding apoproteins. There was also a large difference in
the stability of individual CYP enzymes from different liver donors,
particularly for the most rapidly declining CYP enzymes. Similar losses
of CYP enzymes were found when human liver slices were cultured in
supplemented Williams' medium E for 72 h, except that CYP2E1
apoprotein levels were better maintained. Because of the variable
decreases of CYP enzymes, xenobiotic metabolism studies are best
performed with freshly cut rather than cultured human liver slices.
| |
Introduction |
|---|
|
|
|---|
Hepatic cytochrome P450
(CYP)1 enzymes are
known to have a major role in the metabolism of both xenobiotics
(including therapeutic agents) and certain endogenous compounds
(Conney, 1986
; Nelson et al., 1996
; Parkinson, 1996
; Pelkonen et al.,
1998
). In recent years there has been much interest in the development
of in vitro systems to study the metabolism and toxicity of new
chemical entities. Available liver in vitro models include
precision-cut liver slices, hepatocytes, subcellular fractions,
heterologous expression systems, and permanent and immortalized cell
lines (Wrighton et al., 1995
; Paine, 1996
; Lake, 1997
).
Depending on the desired application, these various liver in vitro
models have both advantages and disadvantages. For example, although
containing only a limited range of xenobiotic-metabolizing enzymes,
preparations of liver microsomes can be stored for extended periods
(Wrighton et al., 1995
; Pearce et al., 1996
). In contrast, hepatocytes
and precision-cut liver slices possess a full range of phase I and II
xenobiotic-metabolizing enzyme activities. However, total CYP content
and individual CYP enzymes are known to decline with time in cultured
rodent and human hepatocytes (Paine, 1990
; LeCluyse et al., 1996
;
Maurel, 1996
). Although xenobiotic-metabolizing enzymes may be stable
for short periods in rat liver slices (Ekins, 1996
), a decline in
xenobiotic-metabolizing enzymes and total CYP content has been reported
in cultured rat liver slices (Wright and Paine, 1992
; Lake et al.,
1993
; Jensen et al., 1997
; Müller et al., 1998
).
To date, few investigations have examined the stability of
xenobiotic-metabolizing enzymes in cultured precision-cut human liver
slices. Based on immunoblotting of freshly cut and 72-h cultured human
liver slice microsomes, a fall in the levels of CYP1A2 and CYP3A4 has
been reported (Lake et al., 1996
, 1997
, 1998
). In addition,
VandenBranden et al. (1998)
reported the loss of a number of
CYP-dependent enzyme activities in human liver slices cultured for up
to 96 h.
The aim of this study was to examine the stability of the major hepatic
CYP enzymes in cultured human liver slices. Levels of CYP1A2, CYP2A6,
CYP2B6, CYP2D6, CYP2E1, CYP3A4, CYP3A5, and CYP4A11 were quantified by
immunoblotting with a panel of monospecific antipeptide antibodies
(Edwards et al., 1998
). In addition, levels of CYP2C enzymes were
quantified with an antibody that binds to CYP2C8, CYP2C9, and CYP2C19,
these CYP forms being readily separated by SDS-polyacrylamide gel
electrophoresis (Edwards et al., 1998
). Finally, enzymatic markers for
CYP1A2, CYP2C9, CYP2D6, and CYP3A4, i.e., 7-ethoxyresorufin
O-deethylase, tolbutamide methylhydroxylase, debrisoquine
4-hydroxylase, and testosterone 6
-hydroxylase, respectively, were
also determined.
| |
Materials and Methods |
|---|
|
|
|---|
Chemicals.
The sources of the tissue culture materials were as described
previously (Beamand et al., 1993
). Debrisoquine, 7-ethoxyresorufin, testosterone, tolbutamide, resorufin, 6
-hydroxytestosterone, enzyme
cofactors, prestained molecular weight markers, and protein G coupled
to horseradish peroxidase were purchased from Sigma-Aldrich Co. Ltd.
(Poole, Dorset, UK), and 4-hydroxydebrisoquine and hydroxytolbutamide were obtained from Salford Ultrafine Chemicals and Research Ltd. (Manchester, UK). [Guanidine-14C]debrisoquine
(specific activity, 55 mCi/mmol) and
[4-14C]testosterone (specific activity, 56 mCi/mmol) were obtained from Amersham International plc (Little
Chalfont, Bucks, UK), and SDS-polyacrylamide gel electrophoresis
reagents from National Diagnostics (Aylesbury, Bucks, UK).
Preparation of Liver Slices. Samples of human liver were collected and transported to TNO BIBRA on ice. The donors of the eight human liver samples, designated subjects A to H, were a male aged 21/2 years, a female aged 12 years, males aged 15 and 17 years, and females aged 74, 31, 38, and 55 years. The Research Ethics Committee of King's College Hospital granted approval for the use of this tissue, which was surplus to clinical requirements. Tissue cylinders from liver samples were prepared using a 10-mm diameter motor-driven tissue-coring tool. From the cylinders, tissue slices (200-300 µm) were prepared in oxygenated (95% O2/5% CO2) Earle's balanced salt solution containing 25 mM D-glucose, 50 µg/ml gentamicin, and 2.5 µg/ml fungizone at room temperature using a Krumdieck tissue slicer (Alabama Research and Development Corp., Munford, AL).
Culture of Liver Slices. Liver slices were floated onto Vitron Inc. (Tucson, AZ) type C titanium roller inserts (two slices per insert) and cultured at 2 rpm in glass vials containing 1.7 ml of culture medium using a Vitron dynamic organ culture incubator. The incubator was operated in accordance with the manufacturer's instructions. For studies with liver samples A to E, the culture medium consisted of RPMI 1640 containing 5% (v/v) fetal calf serum, 0.5 mM (final concentration) L-methionine, 1 µM insulin, 0.1 mM hydrocortisone-21-hemisuccinate, 50 µg/ml gentamicin, and 2.5 µg/ml fungizone. Liver slice cultures were maintained at 37°C in an atmosphere of 95% O2/5% CO2. After 1 h, the medium was changed to fresh culture medium, and subsequently the medium was changed every 24 h. Following each medium change and returning the vials to the incubator, the gas flow was increased for 10 s to restore the high oxygen atmosphere. In the studies with liver samples F to H, the culture medium consisted of serum-free Williams' medium E containing 2 mM L-glutamine, 0.1 µM insulin, 0.1 µM dexamethasone, 50 µg/ml gentamicin and 2.5 µg/ml fungizone. Liver slice cultures were maintained as described above with medium changes after 1 h and subsequently every 24 h.
Biochemical Investigations with Liver Slices.
At the end of the culture periods, the liver slices were washed in
ice-cold 0.154 M KCl containing 50 mM Tris-HCl, pH 7.4, homogenized in
this medium by sonication (Beamand et al., 1993
), and stored at
80°C. Liver slice homogenates (prepared from 16-20 slices) were
centrifuged at 10,000g av for 15 min to obtain the postmitochondrial supernatant fraction and subsequently at
158,000g average centrifugal force for 40 min to separate
the microsomal fraction from the cytosol. Microsomal fractions were
resuspended in 0.154 M KCl containing 50 mM Tris-HCl, pH 7.4, and 2 mM
EDTA, and aliquots were stored at
80°C. Protein was determined by
the method of Lowry et al. (1951)
using bovine serum albumin as
standard. Liver slice unwashed microsomal fractions were assayed for
activities of 7-ethoxyresorufin O-deethylase, tolbutamide
methylhydroxylase, debrisoquine 4-hydroxylase, and testosterone
6
-hydroxylase as markers of CYP1A2, CYP2C9, CYP2D6, and CYP3A4,
respectively. 7-Ethoxyresorufin O-deethylase activity was
determined directly at 37°C in spectrofluorimeter cuvettes containing
2 µM 7-ethoxyresorufin, 0.5 mM NADP+, 7.5 mM
DL-isocitric acid, 0.5 U/ml of isocitric
dehydrogenase, 5 mM MgSO4, 0.15 to 0.70 mg of
microsomal protein, and 50 mM Tris-HCl buffer, pH 8.4, in a final
volume of 2 ml. Resorufin formation was monitored at wavelengths of
535-nm excitation and 582-nm emission. Tolbutamide methylhydroxylase
was determined in incubation mixtures containing 1 mM tolbutamide, 1 mM
NADP+, 7.5 mM DL-isocitric
acid, 2 U/ml isocitric dehydrogenase, 5 mM MgSO4,
0.3 to 0.4 mg of microsomal protein, and 0.1 M phosphate buffer, pH
7.4, in a final volume of 0.5 ml. Incubations were terminated after 30 min with 0.02 ml of 70% (v/v) perchloric acid, and the
supernatant was analyzed by high performance liquid chromatography (HPLC). Chromatography was performed with a 150- × 4.6-mm column of
Supelcosil-5 LC-ABZ protected by a 20- × 4-mm column of Supelcosil-5 LC-ABZ and a mobile phase consisting of 30% (v/v) acetonitrile and
70% (v/v) 20 mM sodium perchlorate, pH 2.5, at a flow rate of 2 ml/min. The eluant was monitored at 230 nm. Debrisoquine 4-hydroxylase
was determined in incubation mixtures containing 1 mM
[guanidine-14C]debrisoquine (0.5 µCi/tube),
1.0 mM NADP, 7.5 mM DL-isocitric acid, 2 U/ml
isocitric dehydrogenase, 5 mM MgSO4, 0.15 to 0.30 mg of microsomal protein, and 0.1 M phosphate buffer, pH 7.4, in a
final volume of 0.25 ml. Incubations were terminated after 60 min with
0.02 ml of 70% (v/v) perchloric acid, and the supernatant was taken
for HPLC analysis. Chromatography was performed as described for
tolbutamide methylhydroxylase, but using a mobile phase of 12% (v/v)
acetonitrile and 88% (v/v) 20 mM sodium perchlorate, pH 2.5, with
quantitation by liquid scintillation counting. Testosterone 6
-hydroxylase was determined in incubation mixtures containing 0.25 mM [4-14C]testosterone (0.25 µCi/tube), 1 mM
NADPH, 0.10 to 0.47 mg of microsomal protein, and 50 mM Tris-HCl
buffer, pH 7.4, in a final volume of 1 ml. Incubations were terminated
after 30 min with 6 ml of dichloromethane and processed for HPLC
analysis with quantitation by liquid scintillation counting as
described by Sonderfan et al. (1987)
.
Immunoblotting.
Immunoblotting was performed using 10 to 100 µg of liver slice
unwashed microsomal protein, as appropriate, under conditions previously described (Edwards et al., 1988
, 1994
). Microsomal proteins
were separated by SDS-polyacrylamide gel electrophoresis using 9%
(w/v) polyacrylamide gels and electrotransferred onto nitrocellulose
filters. The immunoblots were then developed for immunoreactivity using
the respective antiserum containing antibodies targeted against CYP1A2
(diluted 1:4000), CYP2A6 (diluted 1:1000), CYP2B6 (diluted 1:4000),
CYP2C forms (diluted 1:4000), CYP2D6 (diluted 1:1000), CYP2E1 (diluted
1:4000), CYP3A4 (diluted 1:4000), CYP3A5 (diluted 1:4000), or CYP4A11
(diluted 1:1000). All antibodies had previously been shown to be
specific for their target protein (Edwards et al., 1998
). Antibody
binding was detected using protein G coupled to horseradish peroxidase
(12.5 ng/ml), visualized using enhanced chemiluminescence reagents, and
recorded on Hyperfilm. The relative intensity of the
immunoreactive bands was determined by laser densitometry using an LKB
Ultrascan XL Enhanced Densitometer (Pharmacia LKB Biotechnology, St.
Albans, Herts, UK).
Additional Studies with Liver Sample Microsomal Fractions.
Liver samples used to prepare the freshly cut human liver slices were
stored at
80°C. The samples were thawed, and washed microsomal
fractions were prepared as described previously (Lake, 1987
). Whole
homogenates (0.25 g of tissue/ml) were prepared in ice-cold 0.154 M KCl
containing 50 mM Tris-HCl, pH 7.4, using a Potter-type, Teflon-glass,
motor-driven homogenizer (A. H. Thomas, Philadelphia, PA). Liver
whole homogenates were centrifuged at 10,000g av for 20 min
to obtain the postmitochondrial fractions and subsequently at
158,000g av for 40 min to separate the microsomal fraction
from the cytosol. The microsomal fraction was resuspended in fresh
homogenizing medium and again centrifuged at 158,000g av for
40 min. To mimic the preparation of the liver slices, thin slivers of
liver were cut from the liver samples. Whole homogenates were prepared
by sonication, and unwashed microsomal fractions were obtained as
described above for the freshly cut and cultured liver slices. Liver
sample washed liver microsomes and the unwashed microsomal fractions
from the sonicated liver slivers were assayed for 7-ethoxyresorufin
O-deethylase and testosterone 6
-hydroxylase activities as
described above.
Statistical Analysis. Statistical evaluation of data was performed using two-way ANOVA and Student's t test (PRISM and INSTAT; Graphpad Software Inc., San Diego, CA). CYP enzyme half-lives were derived using semilog plots of CYP levels (either from individual livers or using data pooled from all livers) against time and the equation for the line of best fit established by linear regression analysis (FigP Software Corp., Durham, NC). From this equation, the time at which half-maximal CYP levels occurred was identified and used as the half-life.
| |
Results |
|---|
|
|
|---|
Precision-cut human liver slices were prepared from five donors (subjects A to E) and cultured in RPMI 1640 medium containing 5% fetal calf serum and other additions for periods of 1, 24, 48, and 72 h. Microsomal preparations were prepared from freshly cut and cultured liver slices. Because of the small amounts of material available, it was not possible to perform all the measurements on all human liver slice preparations. Moreover, because of the small amounts of tissue, we prepared unwashed microsomal fractions from sonicated liver slice whole homogenates (see Materials and Methods).
CYP Levels in Freshly Cut Slices and Slices Cultured for 1 h.
Immunoblotting of liver slice microsomes was performed to assess the
relative levels of CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2D6,
CYP2E1, CYP3A4, CYP3A5, and CYP4A11. Generally, there was little
difference between levels of any of the CYP apoproteins measured in
microsomes from freshly cut and 1-h cultured human liver slices (Fig.
1). The activities of 7-ethoxyresorufin
O-deethylase, tolbutamide methylhydroxylase, debrisoquine
4-hydroxylase, and testosterone 6
-hydroxylase were determined as
enzymatic markers for CYP1A2, CYP2C9, CYP2D6, and CYP3A4, respectively
(Wrighton et al., 1995
; Parkinson, 1996
; Pelkonen et al., 1998
).
Although the activities of 7-ethoxyresorufin O-deethylase,
tolbutamide methylhydroxylase, and testosterone 6
-hydroxylase were
similar in microsomes from freshly cut and 1-h cultured human liver
slices, debrisoquine 4-hydroxylase activity was somewhat higher in 1-h cultured liver slice microsomes (Table
1).
|
|
-hydroxylase activity was 1186 pmol/min/mg of protein
(mean of two liver samples). These enzyme activities are within the
ranges observed for other preparations of human liver microsomes used
in our laboratories (Edwards et al., 1994
-hydroxylase activities were 24.6 and 661 pmol/min/mg of protein,
respectively. These activities were thus only 50 and 56%,
respectively, of the liver sample washed microsome activities. Although
the liver slice microsomal enzyme activities reported in Table 1 are at
the low end of the range of enzyme activities normally observed in
human liver microsomes, we do not consider that this is due to a lack
of viability of the liver samples used to prepare the freshly cut liver
slices. Rather, as demonstrated by the above additional studies, they
are attributable to the homogenization and centrifugation procedures
used to prepare unwashed microsomes from the freshly cut and cultured
liver slices.
Stability of CYP Enzymes in Cultured Liver Slices. Human liver slices were cultured for up to 72 h, and CYP apoprotein levels were measured in microsomes prepared from the slices. The level of each CYP apoprotein declined with time in culture, although there was considerable variation in the rates of decrease of the 10 different CYP enzymes (Fig. 2). Figure 3 shows mean data for the 10 CYP enzymes, together with a single experiment where CYP2B6 apoprotein levels were also quantified. The levels of CYP2C9, CYP2D6, CYP3A4, and CYP4A11 were relatively stable (Fig. 3), with 45 to 64% remaining after 72 h in culture and overall half-lives of 70 h or greater (Table 2), whereas CYP1A2, CYP2A6, CYP2C8, CYP2C19, CYP2E1, and CYP3A5 levels declined more rapidly to around 11 to 28% of initial levels after 72 h in culture (Fig. 3), resulting in overall half-lives of between 23 and 36 h (Table 2). Although there was considerable variation in the half-lives of CYP enzymes in liver slices from different donors, there was no relationship between CYP stability and donor liver (P = .135; Kruskal-Wallis nonparametric ANOVA test). Thus, the half-life of each CYP varied independently of other CYP enzymes within each donor liver. As a result of this, variation in the level of each CYP increased progressively during culture. The mean coefficient of variation for all 10 CYP apoproteins was 24% after 1 h in culture, but by 72 h this had increased to 86%. However, there was much less variation in the levels of three of the more stable CYP apoproteins, namely CYP2C9, CYP2D6, and CYP4A11 (Fig. 2).
|
|
|
-hydroxylase activity and CYP3A4 apoprotein content,
and tolbutamide methylhydroxylase activity and CYP2C9 apoprotein
content. However, there was a slight divergence between debrisoquine
4-hydroxylase activity and CYP2D6 levels, with activity remaining
stable over the culture period, whereas apoprotein levels decreased
slightly (P < .001, two-way ANOVA) (Fig. 4).
|
Comparison of Culture Media. The effect of culturing human liver slices in serum-free Williams' medium E was investigated using three additional human liver slice preparations (subjects F to H). The liver slice preparations were cultured for 72 h in serum-free Williams' medium E using different hormone concentrations than those used to culture human liver slices from subjects A to E in the RPMI 1640 medium (see Materials and Methods for details). The levels of 10 CYP apoproteins, i.e., CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1, CYP2D6, CYP3A4, CYP3A5, and CYP4A11, were determined in freshly cut and 72-h cultured human liver slice microsomes (Fig. 5). Compared with the corresponding data for the five human liver slice preparations (subjects A to E) cultured in RPMI 1640 medium containing fetal calf serum, there was no significant difference between levels of CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5, or CYP4A11 apoproteins using Williams' medium E. In contrast, levels of CYP2E1 apoprotein were significantly higher in liver slices cultured in serum-free Williams' medium E than in liver slices cultured in RPMI 1640 with fetal calf serum (Fig. 5).
|
| |
Discussion |
|---|
|
|
|---|
Precision-cut liver slices have been extensively used for studies
of xenobiotic metabolism and xenobiotic-induced toxicity (Parrish et
al., 1995
; Bach et al., 1996
; Olinga et al., 1998
). A major advantage
of this technique is its ready application to the evaluation of species
differences in response. Indeed, valuable data have been obtained from
comparisons between human liver slices and liver slices from other species.
Previous studies have demonstrated that levels of CYP apoprotein and
associated monooxygenase activities decline in cultured rat liver
slices as they do in hepatocytes (Paine, 1990
; Wright and Paine, 1992
;
Lake et al., 1993
; LeCluyse et al., 1996
; Jensen et al., 1997
;
Müller et al., 1998
). Although considered somewhat more stable in
human than in rodent hepatocytes, levels of CYP enzymes also decline
during culture (Guillouzo et al., 1985
, 1993
; Maurice et al.,
1992
; Curi-Pedrosa et al., 1994
; Maurel, 1996
; Strom et al.,
1996
). However, these studies also demonstrate that CYP apoprotein
levels and enzyme activities are readily detectable in human
hepatocytes after several days of culture.
Only a few studies have examined the stability of CYP enzymes in
cultured human liver slices. A decline in levels of CYP1A2 and CYP3A4
has been reported, although levels of these two CYP apoproteins and
associated enzyme activities were detectable in human liver slices
cultured for 72 h in RPMI 1640 medium (Lake et al., 1996
, 1997
,
1998
). In contrast, VandenBranden et al. (1998)
observed marked losses
of CYP enzyme activities in cultured human liver slices.
The current study examined the stability of 11 CYP enzymes in cultured
human liver slices by measuring the relative apoprotein levels of
CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1,
CYP3A4, CYP3A5, and CYP4A11 as well as 7-ethoxyresorufin O-deethylase, tolbutamide methylhydroxylase, debrisoquine
4-hydroxylase, and testosterone 6
-hydroxylase activities. In
general, it was found that CYP enzyme levels decrease with time in
culture. However, under the conditions used in the present study and
contrary to another report (VandenBranden et al., 1998
), they were
reasonably stable, although there was a large (>4-fold) variation in
the rate of decline of different CYP enzymes. The present data,
together with previous studies (Lake et al., 1996
, 1997
, 1998
) suggest that, like human hepatocytes, human liver slices can retain detectable levels of CYP enzymes for at least 72 h when cultured under
appropriate conditions. Some possible reasons for the apparent
discrepancy between the present data and that of VandenBranden et al.
(1998)
are discussed below.
Initially, a comparison was made between CYP apoprotein levels and enzyme activities in microsomes prepared from human liver slices that had been freshly cut after culturing for a short period (1 h of preincubation). There was a good correspondence between both apoprotein levels and enzyme activities, thus indicating that the initial incubation of human liver slices in culture medium has no immediate effect on CYP levels.
Culturing liver slices for up to 72 h resulted in a progressive
decrease in CYP levels with time. Interestingly, CYP enzymes appear to
fall into two groups, with CYP2C9, CYP2D6, CYP3A4, and CYP4A11 being
relatively stable (half-lives between 70 and 104 h) compared with
CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C19, CYP2E1, and CYP3A5, which were
relatively unstable (half-lives between 23 and 36 h). Although the
majority of this study was carried out by measuring the levels of CYP
apoproteins, the data that were obtained on enzyme activities suggest
that these conclusions apply to loss of holoenzyme as well as to
apoprotein. Hence, similar half-lives were found for 7-ethoxyresorufin
O-deethylase activity and CYP1A2 apoprotein content,
testosterone 6
-hydroxylase activity and CYP3A4 apoprotein content,
and tolbutamide methylhydroxylase activity and CYP2C9 apoprotein
content. Although there was a slight deviation between debrisoquine
4-hydroxylase activity and CYP2D6 apoprotein levels, it is clear that
both remained relatively stable over the culture period.
As well as variations in the half-life of different CYP enzymes, large differences existed in the stability of individual CYP enzymes in liver slices from different donors. This was particularly so among the most rapidly declining CYP enzymes. This does not appear to be related to the donor or the quality of the liver samples because no relationship was found between maintenance of the levels of different CYP enzymes in individual liver samples.
The reason for the decline in CYP enzyme levels during culture is not
known, but a number of possible explanations have been suggested,
including cellular dedifferentiation, medium composition, and
endogenous degradative processes. For example, studies with cultured
human hepatocytes have led to the suggestion that a progressive loss of
viability or increased dedifferentiation may be causal in the reduction
of CYP levels (Guillouzo et al., 1985
, 1993
; Maurice et al., 1992
;
Maurel, 1996
), and it is possible that these factors may also be
important in cultured liver slices.
Maurel (1996)
has also suggested that the loss of inducible CYP
enzymes, including CYP1A2 and CYP3A4, is due to the culture of the
cells in a chemically defined medium lacking inducers. This would
explain the relative stability of CYP2D6 in cultured human hepatocytes
(Maurel, 1996
) because this CYP enzyme is not believed to be inducible
by xenobiotics, unlike members of the CYP1A, CYP2A, CYP2B, CYP2C,
CYP2E, and CYP3A subfamilies (Wrighton et al., 1995
; Maurel, 1996
;
Parkinson, 1996
; Miners and Birkett, 1998
; Pelkonen et al., 1998
).
Certainly, in the present study, CYP2D6 was relatively stable. However,
CYP2C9, CYP3A4, and CYP4A11 were found to have similar stabilities to
CYP2D6. Although the inducibility of CYP4A11 in humans is not known,
both CYP2C9 and CYP3A4 are inducible by various compounds (Watkins et
al., 1985
; Maurel, 1996
; Parkinson, 1996
; Miners and Birkett, 1998
;
Pelkonen et al., 1998
). Hence the loss of CYP enzymes in cultured human liver slices cannot be solely attributed to the absence of CYP enzyme
inducers from the culture medium.
Studies with precision-cut rat liver slices have demonstrated that not
all culture media adequately maintain liver slice viability (Beamand et
al., 1993
; Fisher et al., 1995a
; Bach et al., 1996
; Renwick et al.,
1999
). In the present study, limited comparisons were made between RPMI
1640 medium with fetal calf serum and serum-free Williams' medium E. Both media were supplemented with insulin and a glucocorticoid
(dexamethasone or hydrocortisone). Apart from an apparent higher
maintenance of CYP2E1 apoprotein in liver slices cultured in Williams'
medium E, no marked differences were observed in the ability of these
two media to maintain CYP apoprotein levels in liver slices cultured
for 72 h. However, comparisons between culture media and culture
media additions are best performed with the same batches of
liver slices and not with two separate batches (i.e., subjects A to E
and F to H) as shown in Fig. 5. Clearly there is scope for further
studies to optimize culture conditions for the maintenance of CYP
enzymes in cultured human liver slices.
Studies on the degradation of proteins in the endoplasmic reticulum
have shown that rodent CYP enzymes have relatively short half-lives
compared with other proteins, including NADPH P450 reductase and
cytochrome b5. This suggests that specific
biochemical mechanisms exist for their degradation (Correia, 1991
), as
confirmed by different rates and routes of proteasomal CYP digestion
(Roberts, 1997
). The routes and relative activities of degradative
pathways may account for differences in the half-lives of CYP enzymes
and may also contribute to the observed interindividual differences.
Recently, VandenBranden et al. (1998)
examined the stability of a range
of monooxygenase activities representing CYP1A2, CYP2A6, CYP2B6,
CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4 in three human liver slice
preparations cultured for up to 96 h. Unlike the present study,
they reported marked losses of all CYP enzyme activities within 24 h, with some enzyme activities decreasing to undetectable levels after
48 h in culture. There are both apparent similarities and
differences between our experimental protocol and that of VandenBranden
et al. (1998)
. In both studies, the liver slices were cultured using a
dynamic organ culture system under a high oxygen atmosphere. Certainly
investigations with rat liver slices have demonstrated that a high
oxygen atmosphere is generally preferable to air as the gas phase
(Fisher et al., 1995a
,b
; Price et al., 1998
), and we have utilized such
conditions for 72-h CYP enzyme induction studies in human liver slices
(Lake et al., 1997
, 1998
). In both the study of VandenBranden et al.
(1998)
and the present study, the culture medium was supplemented with
gentamicin and fungizone, which suggests that neither of these agents
was responsible for the observed differential effects on CYP enzyme
stability. Although we used either RPMI 1640 or Williams' medium E and
VandenBranden et al. (1998)
used Waymouth's medium, other studies with
rat liver slices have failed to demonstrate any marked differences
between these three media (Fisher et al., 1995b
; Renwick et al., 1999
). The presence or absence of fetal calf serum in the medium also does not
appear to markedly influence CYP enzyme stability, as illustrated by
the limited comparisons between RPMI 1640 plus fetal calf serum and
serum-free Williams' medium E (Fig. 5). However, unlike VandenBranden
et al. (1998)
, we supplemented our media with insulin and a
glucocorticoid (hydrocortisone or dexamethasone). Although additional
studies are required to confirm and extend these observations, the
present data suggest that these hormones help maintain liver slice
viability and levels of CYP enzymes. Certainly, insulin and a
glucocorticoid are often added to human hepatocyte cultures for CYP
enzyme induction and other studies (Guillouzo et al., 1985
; Maurice et
al., 1992
; Curi-Pedrosa et al., 1994
; Strom et al., 1996
).
In summary, the fall in levels of CYP enzymes and associated enzyme activities in cultured human liver slices indicates that xenobiotic metabolism studies are best performed with freshly cut rather than with cultured human liver slices. Prolonged culture periods, which may be necessary for slowly metabolized xenobiotics, will result in a differential loss of CYP enzymes, and this may lead to inaccuracies in the prediction of quantitative differences between pathways of metabolism.
| |
Footnotes |
|---|
Received May 4, 1999; accepted June 20, 2000.
The provision of financial support by a grant from the Commission of the European Communities (Project "Eurocyp", BIOMED Contract No. BMH4-CT96-0254) and a Realizing Our Potential Award from the Medical Research Council are gratefully acknowledged.
Send reprint requests to: Dr. Brian G. Lake, TNO BIBRA International Ltd, Woodmansterne Rd., Carshalton, Surrey, SM5 4DS, UK. E-mail: blake{at}bibra.co.uk
| |
Abbreviations |
|---|
Abbreviation used is: CYP, cytochrome P450.
| |
References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
X. Zhang, S. K. Quinney, J. C. Gorski, D. R. Jones, and S. D. Hall Semiphysiologically Based Pharmacokinetic Models for the Inhibition of Midazolam Clearance by Diltiazem and Its Major Metabolite Drug Metab. Dispos., August 1, 2009; 37(8): 1587 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. van de Kerkhof, I. A. M. de Graaf, A.-L. B. Ungell, and G. M. M. Groothuis Induction of Metabolism and Transport in Human Intestine: Validation of Precision-Cut Slices as a Tool to Study Induction of Drug Metabolism in Human Intestine in Vitro Drug Metab. Dispos., March 1, 2008; 36(3): 604 - 613. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. van de Kerkhof, I. A. M. de Graaf, M. H. de Jager, and G. M. M. Groothuis Induction of Phase I and II Drug Metabolism in Rat Small Intestine and Colon in Vitro Drug Metab. Dispos., June 1, 2007; 35(6): 898 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Karjalainen, P. J. Neuvonen, and J. T. Backman Rofecoxib Is a Potent, Metabolism-Dependent Inhibitor of CYP1A2: Implications for in Vitro Prediction of Drug Interactions Drug Metab. Dispos., December 1, 2006; 34(12): 2091 - 2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Van, A. Heydari, J. Yang, J. Hargreaves, K. Rowland-Yeo, M. S. Lennard, G. T. Tucker, and A. Rostami-Hodjegan The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy) J Psychopharmacol, November 1, 2006; 20(6): 834 - 841. [Abstract] [PDF] |
||||
![]() |
J. Yang, M. Jamei, A. Heydari, K. R. Yeo, R. de la Torre, M. Farre, G. T. Tucker, and A. Rostami-Hodjegan Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA J Psychopharmacol, November 1, 2006; 20(6): 842 - 849. [Abstract] [PDF] |
||||
![]() |
E. G. van de Kerkhof, A.-L. B. Ungell, A. K. Sjoberg, M. H. de Jager, C. Hilgendorf, I. A. M. de Graaf, and G. M. M. Groothuis Innovative Methods to Study Human Intestinal Drug Metabolism in Vitro: Precision-Cut Slices Compared with Ussing Chamber Preparations Drug Metab. Dispos., November 1, 2006; 34(11): 1893 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. M. de Graaf, R. de Kanter, M. H. de Jager, R. Camacho, E. Langenkamp, E. G. van de Kerkhof, and G. M. M. Groothuis EMPIRICAL VALIDATION OF A RAT IN VITRO ORGAN SLICE MODEL AS A TOOL FOR IN VIVO CLEARANCE PREDICTION Drug Metab. Dispos., April 1, 2006; 34(4): 591 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Galetin, H. Burt, L. Gibbons, and J. B. Houston PREDICTION OF TIME-DEPENDENT CYP3A4 DRUG-DRUG INTERACTIONS: IMPACT OF ENZYME DEGRADATION, PARALLEL ELIMINATION PATHWAYS, AND INTESTINAL INHIBITION Drug Metab. Dispos., January 1, 2006; 34(1): 166 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Heydari, K. R. Yeo, M. S. Lennard, S. W. Ellis, G. T. Tucker, and A. Rostami-Hodjegan MECHANISM-BASED INACTIVATION OF CYP2D6 BY METHYLENEDIOXYMETHAMPHETAMINE Drug Metab. Dispos., November 1, 2004; 32(11): 1213 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Christian, M. Lang, P. Maurel, and F. Raffalli-Mathieu Interaction of Heterogeneous Nuclear Ribonucleoprotein A1 with Cytochrome P450 2A6 mRNA: Implications for Post-Transcriptional Regulation of the CYP2A6 Gene Mol. Pharmacol., June 1, 2004; 65(6): 1405 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Evans, D. O'Connor, B. G. Lake, R. Evers, C. Allen, and R. Hargreaves ELETRIPTAN METABOLISM BY HUMAN HEPATIC CYP450 ENZYMES AND TRANSPORT BY HUMAN P-GLYCOPROTEIN Drug Metab. Dispos., July 1, 2003; 31(7): 861 - 869. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Edwards, R. J. Price, P. S. Watts, A. B. Renwick, J. M. Tredger, A. R. Boobis, and B. G. Lake Induction of Cytochrome P450 Enzymes in Cultured Precision-Cut Human Liver Slices Drug Metab. Dispos., March 1, 2003; 31(3): 282 - 288. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||